Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | HLA-E |
| Upstream (Parents) |
|---|
| (<<) AIF1 → HLA-E |
| (<<) C3 → HLA-E |
| (<<) SERPING1 → HLA-E |
| Downstream (Children) |
|---|
| HLA-E → RBBP8 (>>) |
| HLA-E → ACVRL1 (>>) |
| HLA-E → IL4R (>>) |
| HLA-E → NKG7 (>>) |
| HLA-E → BTN3A2 (>>) |
| HLA-E → CYP39A1 (>>) |
| HLA-E → CD1C (>>) |
| HLA-E → RASGRP2 (>>) |
| HLA-E → MAP4K1 (>>) |
| HLA-E → ZFX (>>) |
| HLA-E → LILRB2 (>>) |
| HLA-E → CD8B (>>) |
| HLA-E → NOD2 (>>) |
| HLA-E → NCF4 (>>) |
| HLA-E → TRIM49 (>>) |
| HLA-E → CCDC69 (>>) |
| HLA-E → CALML4 (>>) |
| HLA-E → SLA (>>) |
| HLA-E → FLT3LG (>>) |
| HLA-E → LYL1 (>>) |
| HLA-E → SLC25A30 (>>) |
| HLA-E → CD79B (>>) |
| HLA-E → BAG4 (>>) |
| HLA-E → BTN3A1 (>>) |
| HLA-E → TNFSF14 (>>) |
| HLA-E → OR12D3///OR5V1 (>>) |
| HLA-E → ZBP1 (>>) |
| HLA-E → CLEC10A (>>) |
| HLA-E → ENTPD4///LOXL2 (>>) |
| HLA-E → PLEKHO1 (>>) |
| HLA-E → CD97 (>>) |
| HLA-E → ESM1 (>>) |
| HLA-E → ICAM2 (>>) |
| HLA-E → LGALS9 (>>) |
